SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is gaining traction as a privacy-focused layer-1 blockchain, with recent partnerships sparking increased interest and bullish sentiment. The community is highlighting its focus on regulatory compliance and real-world utility, differentiating it from hype-driven projects. Some users are drawing comparisons to ZCash ($ZEC) and anticipating significant growth potential.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is gaining traction as community members highlight its growing user base, surpassing Solana and Ethereum in active users, which may be driving the current rally. Bullish sentiment is also fueled by discussions around AI integration and staking opportunities within the NEAR ecosystem. Traders are actively monitoring potential breakout setups and key price levels.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos ($XTZ) is trending amid discussions of potential pump and dumps, with community members debating whether recent price movements are sustainable or a trap for "suckers." The conversation revolves around identifying entry and exit points, as well as the coin's long-term potential in the broader crypto market, with some users pointing to its growing supply.

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Carmax Inc

Carmax ($KMX) is trending due to a mix of factors, including a CEO transition and disappointing sales forecasts, leading to a significant stock drop. The community is debating whether this dip presents a buying opportunity, especially given Carmax's valuation relative to competitor Carvana ($CVNA). Some investors believe the stock is oversold and poised for a rebound, while others express concerns about the broader economic outlook and its impact on the used car market.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

$SWEAT is gaining attention as users discuss its potential and unique concept of earning crypto through physical activity. Community members are highlighting its long-term potential and staking opportunities. Some are calling for more immediate gains, while others remain patient, awaiting wider recognition and adoption.

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

NeOnc Technologies Holdings Inc.

NeOnc Technologies is trending following news of a strategic partnership with Quazar Investment, including a significant equity investment at a premium. The community is discussing the potential for clinical trial advancements and infrastructure development in the UAE and MENA region as a result of this deal, with some highlighting the low float and potential for rapid price movement. Recent executive appointments and positive clinical trial updates have also contributed to increased interest in NTHI.

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

FibroGen Inc

FibroGen is trending as investors discuss its pipeline, particularly roxadustat and FG-3246, with some anticipating Phase 2 trial results and potential FDA discussions. The community speculates on potential catalysts, including the completion of the FibroGen China sale to AstraZeneca, and its impact on the company's cash runway. Discussions also involve the possibility of a merger or acquisition, with some highlighting the company's low market cap relative to its assets.

What is DigiByte? DigiByte is more than a faster digital currency. It is an innovative blockchain that can be used for digital assets, smart contracts, decentralized applications and secure authentication.   What makes DigiByte stronger than others? DigiByte is a rapidly growing open-source blockchain created in late 2013 and released in early 2014. After 6 years of forward thinking development, DigiByte has become one of the safest, fastest, longest and most decentralized UTXO blockchain in existence.   Truly Decentralized. DigiByte has never been funded through an ICO or significant amount of premined coins. There is no CEO or a company controlling the DigiByte blockchain. It is a volunteer based and global community driven project.   More secure. DigiByte uses 5 cryptographic algorithms and real time difficulty adjustment to prevent malicious mining centralization and hash power fluctuation. One of which is Odocrypt that changes itself every 10 days for ASIC resistance.   Much faster. DigiByte blocks occur every 15 seconds which is 40x faster than Bitcoin and 10x faster than Litecoin. Early SegWit implementation and blockchain rigidity enable up to 1066 on-chain transactions per second with negligible fees.   Forward thinking. Over the past 6 years, DigiByte has repeatedly set itself apart with multiple blockchain firsts, such asDigiShield guard, MultiAlgo mining, SegWit implementation, Odocrypt algorithm, Dandelion++ privacy protocol, DigiAssets and Digi-ID.       This is how the DigiByte blockchain works. The three layers are the most innovative parts of the DigiByte blockchain providing the network infrastructure, security and communications to function with cutting edge speed.    Applications / DigiAssets. The top layer is like an app store with clear real-world uses. All types of digital assets can be created with the DigiAssets protocol on top of the DigiByte blockchain. Decentralized applications (dApps) can be built on top of the DigiByte blockchain. Also smart contracts that leverage the rigidity and security of the DigiByte blockchain can be encoded easily.   Digital asset / Public ledger. The middle layer provides security and administration. A Digital Byte of data, a representation of larger data or a unit that holds value, and cannot be counterfeited, duplicated or hacked. An immutable public ledger where all transactions of DigiBytes are recorded. DigiByte uses five proof of work algorithms for security. New DigiBytes come from mining only.   Core protocol / Global network. The bottom layer provides communication and operating procedures. A very low-level way nodes on the DigiByte global network communicate. Thousands of people are running DigiByte software all across the planet. Any server, computer, tablet or mobile phone connected to the DigiByte network becomes a node that helps relay transactions.    Open source / Permissionless. Just like the DigiByte.io website, the DigiByte blockchain is completely open source and free to use released under the MIT license, which gives you the power to run and modify the software. Transparency allows for independent verification of binaries and their corresponding source code.        A digital currency you would absolutely love. DigiByte (DGB) is a highly scalable peer-to-peer digital currency that enables industry-leading transaction speeds with negligible fees. DigiByte is the best way for payments.   Easy to use. Getting started to use DigiByte is even easier than sending an SMS. You can send and receive DigiBytes using the devices you already know and love. All you need is installing a DigiByte supported wallet then click scan, scan the QR code and send DigiByte. As easy as 1..2..3.   Not an ICO. DigiByte has never been funded through an ICO or significant amount of premined coins (0% remaining). There is no CEO or a company controlling the DigiByte blockchain. The founder, developers and the community are unpaid volunteers that eliminate the bankrupt risk.   Much faster. DigiByte transactions are confirmed in approx. 15 seconds, which is 40 times faster than Bitcoin and 10 times faster than Litecoin. SegWit enables up to 1066 on-chain transactions per second and negligible fees make DigiByte the ideal currency for daily payments.    Always secure. DigiByte has been built on the uncrackable technology of the Bitcoin blockchain and implemented various advanced enhancements over it such as DigiShield guard, MultiAlgo mining and the Odocrypt algorithm. Also Dandelion++ privacy protocol helps keep you safe by hiding your IP and physical location. Learn more.   Mineable. DigiByte is a 100% Proof of Work (PoW) blockchain that can be mined with five algorithms called Sha256, Scrypt, Skein, Qubit and Odocrypt. MultiAlgo mining contributes to decentralization, security of the network and gives you the freedom to use different kind of hardware's such as an ASIC a FPGA or a GPU. Learn more.   Manageable units Compared to 21 million Bitcoin, 21 billion DigiByte (1000:1 ratio to BTC) have been designed to be ready for mass adoption. DigiByte block rewards reduces by 1% every month instead of halving every 4 years. All 21 billion DigiByte will be mined by the year 2035. After 2035 the miners will then rely on transaction fees alone. Learn more.     A simplified way to create digital assets. DigiAssets is a secure, scalable layer on top of the DigiByte blockchain that allows for the decentralized issuance of assets, tokens, smart contracts, digital identity and more.   Limitless possibilities. DigiAssets can be used to securely represent anything we find in the physical world. From tangible assets such as real estate or cars, through to scarce digital pieces of art. Signed documents such as deeds and medical bills can be protected.   Growing confidently. DigiAssets as an ecosystem and platform already has interested parties either planning on or currently building platforms in real estate, finance, remittance, identity, point of sale, racing, trade, healthcare, supply chain, government and more.   Solid technology. DigiAssets leverages unique aspects of a truly decentralized blockchain only found within a permissionless blockchain like DigiByte. This allows DigiAssets to be more secure, scalable and decentralized than any other platform in the market.      Authentication at its best. Digi-ID is a security protocol built on DigiByte blockchain technology that empowers users to effortlessly sign-in to websites, applications, and even into the internet of things.    Easy authentication. Digi-ID eliminates the username, password and 2fa requirements for authentication. Because Digi-ID uses public / private key cryptography, there are no passwords or usernames at risk. This method not only protects the consumer, it also protects the services that the consumer uses.    Flawless security. Digi-ID does not store any data about its users on the DigiByte blockchain. This further strengthens the security while also bolstering end-user’s confidence that their data is neither tracked nor at risk by others negligence. There is no external point of failure for an hacker to exploit your platform.   Simple and free. Digi-ID is completely free! There are no fees, subscription services, or maintenance costs. But the cost is its second best feature. Its primary feature is that, in accordance with DigiBytes security prioritization, Digi-ID is a more secure, yet simple method available to log in to websites, apps and more.     The most passionate community ever! Tens of thousands of volunteers from all over the world have contributed to DigiByte in countless ways for years to make it what it is today. It is a truly grassroots movement. We warmly welcome you to join us!   DigiByte Foundation. The DigiByte Foundation is a volunteer managed organization that operates in a non-profit way. They protect and promote the true principles of decentralization and empower DigiByte and its community to establish and maintain a sustainable decentralized world. Learn more.    DigiByte Awareness Team.  DGBAT is a community-driven outreach initiative. They are led by a team, whose members in turn manage teams across social media, outreach, education, writers and developers. They aim to promote the DigiByte blockchain through education, outreach and marketing campaigns. Learn more.    DigiByte Developers.  Everyone that is working on the DigiByte blockchain is an unpaid volunteer who devoted their time and skills to a project they believe in. Start contributing to the DGB development today or build your own app on top of the DigiByte blockchain. DigiByte Protocol on GitHub. DigiByte Core Development on GitHub.   The DigiByte Wiki. The DigiByte Wiki is an online encyclopedia built by the community, for the community. It contains useful and up to date data such as the DigiByte Ecosystem and how to guides. Anyone can positively contribute to the Wiki by creating a free user account and start adding or updating information on the DigiByte Wiki.    Meet the creator of DigiByte. Jared Tate is the founder and creator of the DigiByte blockchain. Jared dedicated full-time development towards DigiByte since October 2013. He has been invited by MIT, Harvard and the US Capitol to speak on blockchain tech. He is also the author of the book Blockchain 2035 The Digital DNA of Internet 3.0, which is the first book written by a blockchain founder.

DigiByte

DigiByte is trending as the crypto community discusses its recent price action and potential. Bullish sentiment is growing due to its resilience in a down market and the upcoming Taproot activation, with some speculating about exchange listings. Community members are also highlighting DigiByte's fundamentals, such as its decentralization, security, and fast transaction speeds, comparing it favorably to Bitcoin.

Exelon Corp. is a utility services holding company, which engages in the energy distribution and transmission businesses. It operates through the following segments: Commonwealth Edison Company, PECO Energy Company, Baltimore Gas and Electric Company, Potomac Electric Power Company, Delmarva Power and Light Company, and Atlantic City Electric Company. The company was founded on February 4, 1999 and is headquartered in Chicago, IL.

Exelon Corp.

Exelon is trending due to a combination of factors, including recent earnings beats and analyst upgrades, with community members discussing the company's infrastructure investments and potential for growth in the utility sector. Discussions also involve the company's focus on clean energy and its role in meeting increasing power demands. Technical analysis and options trading strategies are also contributing to the ongoing interest in EXC.

Expedia Group, Inc. is an online travel company, which engages in the provision of travel products and services to leisure and corporate travelers. It operates through the following segments: B2C, B2B, and Trivago. The B2C segment offers a full range of travel and advertising services to worldwide customers through a variety of consumer brands. The B2B segment refers to a wide range of travel and non-travel companies including airlines, offline travel agents, online retailers, corporate travel management, and financial institutions. The Trivago segment generates advertising revenue primarily from sending referrals to online travel companies and travel service providers from hotel metasearch websites. The company was founded in 1994 and is headquartered in Seattle, WA.

Expedia Group Inc

Expedia's stock is trending following reports of a potential acquisition by Uber, driving community discussion about the strategic fit and valuation. The news comes after a period of strong performance, with some analysts pointing to Expedia's undervalued status compared to peers. Community members are weighing the potential benefits of a merger against concerns about market concentration and regulatory hurdles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aquestive Therapeutics (NASDAQ:AQST) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised Aquestive Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Aquestive Therapeutics (NASDAQ:AQST) Releases Earnings Results

Aquestive Therapeutics (NASDAQ:AQST - Get Free Report) released its earnings results on Wednesday. The company reported ($0.14) earnings per share for the quarter, missing analysts' consensus...

Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings

Although the revenue and EPS for Aquestive Therapeutics (AQST) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -7.69% and -4.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year?

Here is how DBV Technologies S.A. (DBVT) and Aquestive Therapeutics (AQST) have performed compared to their sector so far this year.

Are Medical Stocks Lagging  Aquestive Therapeutics (AQST) This Year?

Here is how Aquestive Therapeutics (AQST) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.

Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains?

Aquestive Therapeutics (AQST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Shares of Aquestive Therapeutics jumped more than 11% in after-hours trading Thursday after CEO Dan Barber said the company’s oral epinephrine film, Anaphylm, could become a “blockbuster” drug with as much as $1 billion in peak global sales.Barber&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/video/2025/09/25/aquestive-ceo-on-its-potential-1-billion-blockbuster-product.html">said in an interview</a> on CNBC’s "Mad Money" with Jim Cramer, noting that despite winning six FDA approvals and distributing 2.5 billion doses worldwide over the past two decades, Aquestive has historically remained small, with annual revenue of $50 million to $70 million.&nbsp;He said Anaphylm, designed to treat severe allergic reactions with a dissolvable sublingual film instead of an auto-injector, represents the company’s first chance at a broad-market product.Cramer, who first highlighted the stock earlier this month as a speculative pick, pointed to Anaphylm’s potential as an alternative to epinephrine auto-injectors like the EpiPen.Earlier this month, Aquestive said that the FDA has determined an advisory committee meeting is not required for Anaphylm, maintaining the Prescription Drug User Fee Act target action date of January 31, 2026.&nbsp;Oppenheimer raised its price target on Aquestive to $8 from $7 following the announcement, reiterating its ‘Outperform’ rating and noting that investors interpret the FDA decision as increasing the chances of approval.The company has also outlined its regulatory strategy outside the U.S., saying in July that Health Canada granted a meeting to discuss its planned New Drug Submission for Anaphylm and that an initial briefing package has been submitted to the European Medicines Agency.&nbsp;Aquestive said Canada and Europe represent “ideal initial international markets” for the drug, given regulatory alignment and patient need.To prepare for a potential launch, Aquestive has raised about $160 million in financing, which Barber said positions the company to ensure broad outreach to providers, caregivers, and patients once the FDA decision is made.On Stocktwits, retail sentiment for Aquestive was ‘bullish’ amid ‘high’ message volume.One user said that Barber’s appearance on&nbsp;CNBC’s “Mad Money” show&nbsp;was a turning point for Aquestive Therapeutics, saying the CEO “really painted the company in a great light” by backing up Anaphylm’s projected value with current epinephrine market data.&nbsp;<stembedurl>https://stocktwits.com/YaBoyJ313/message/630079945</stembedurl>Another user suggested that Aquestive could become a buyout target within two years of Anaphylm sales, predicting the stock could climb from about $10 to $25 if that scenario&nbsp;were to play out.<stembedurl>https://stocktwits.com/ImPoorAndHungry/message/630067707</stembedurl><a href="https://stocktwits.com/symbol/AQST">Aquestive’s stock</a> has risen 47.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Aquestive’s stock (AQST) has risen 47.8% so far in 2025. (Photo credit: Getty Images)

Aquestive Stock Jumps After-Hours As CEO Sees $1B ‘Blockbuster’ Potential For Oral Allergy Film — Retail Sees Stock As Buyout Candidate

Aquestive’s Anaphylm has drawn heightened investor attention after the CEO spotlighted it as the company’s first broad-market product.

Why Aquestive Therapeutics Stock Jumped After-Hours Today

Equity

Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock?

Aquestive Therapeutics (AQST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA

Aquestive Therapeutics shares surge after FDA skips advisory meeting on Anaphylm NDA, keeping its January 2026 action date intact.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$6.04
Prev Close	$6.13
Open	$6.41
Dividend Yield	0.00%
50-Day Moving Average	$5.88
Beta	1.37
Avg. Volume	2.98M
PE Ratio	-8.59

52-Week High	$7.55
52-Week Low	$2.12
Market Capitalization	$730.68M
EPS (Annual)	-$0.5089
Price to Book	-178.86
Revenue Per Employee	$405,359.16
Enterprise Value/EBITDA	N/A

AQST
Aquestive Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AQST News

AQSTAquestive Therapeutics Inc